A Rare Disease Leading to Hypertension.
Jing Chen,Xin Chen,Anna F. Dominiczak,Robert M. Carey,Cheryl L. Laffer,Fernando Elijovich,Sandra J. Taler,Tanja Dudenbostel,Rhian M. Touyz,Ji-Guang Wang
DOI: https://doi.org/10.1161/hypertensionaha.122.18678
IF: 9.8968
2022-01-01
Hypertension
Abstract:HomeHypertensionVol. 79, No. 6A Rare Disease Leading to Hypertension Free AccessCase ReportPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessCase ReportPDF/EPUBA Rare Disease Leading to Hypertension Jing Chen, Xin Chen, Anna F. Dominiczak, Robert M. Carey, Cheryl L. Laffer, Fernando Elijovich, Sandra J. Taler, Tanja Dudenbostel, Rhian M. Touyz and Ji-Guang Wang Jing ChenJing Chen Department of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China (J.C., X.C.). , Xin ChenXin Chen https://orcid.org/0000-0002-7970-6991 Department of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China (J.C., X.C.). , Anna F. DominiczakAnna F. Dominiczak https://orcid.org/0000-0003-4913-3608 BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Scotland, United Kingdom (A.F.D.). , Robert M. CareyRobert M. Carey https://orcid.org/0000-0001-7238-7396 Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia Health System, Charlottesville (R.M.C.). , Cheryl L. LafferCheryl L. Laffer https://orcid.org/0000-0002-6453-6010 Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN (C.L.L., F.E.). , Fernando ElijovichFernando Elijovich https://orcid.org/0000-0002-2511-056X Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN (C.L.L., F.E.). , Sandra J. TalerSandra J. Taler Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN (S.J.T.). , Tanja DudenbostelTanja Dudenbostel https://orcid.org/0000-0003-3260-8363 Vascular Biology and Hypertension Program, Division of Cardiovascular Disease, Department of Medicine, University of Alabama, Birmingham (T.D.). , Rhian M. TouyzRhian M. Touyz https://orcid.org/0000-0003-0670-0887 Research Institute of the McGill University Health Centre, McGill University, Montreal, Canada (R.M.T.). and Ji-Guang WangJi-Guang Wang Correspondence to: Ji-Guang Wang, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197 Ruijin 2nd Rd, Shanghai 200025, China. Email E-mail Address: [email protected] https://orcid.org/0000-0001-8511-1524 Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China (J.-G.W.). Originally published18 Mar 2022https://doi.org/10.1161/HYPERTENSIONAHA.122.18678Hypertension. 2022;79:1147–1152Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: March 18, 2022: Ahead of Print Case ReportA 17-year-old man was admitted to our clinic with high blood pressure 1 year ago. When he was in military training in preparation for admission to college, physical examination showed high blood pressure (≈220/115 mm Hg). He was admitted to the local hospital for treatment. During hospitalization, sex hormone testing showed elevated levels of estradiol, LH (luteinizing hormone), and FSH (follicle-stimulating hormone; Table 1), while other blood and urine tests were normal. He was found to have a Rathke cleft cyst through magnetic resonance imaging scan. He was referred to our hospital for management of resistant hypertension. Despite initiation of 3 antihypertensive drugs including nifedipine gastrointestinal therapeutic system 30 mg BID, carvedilol 10 mg BID, and terazosin 2 mg BID, his office blood pressure was poorly controlled with a blood pressure of 189/92 mm Hg. Ambulatory blood pressure monitoring revealed average blood pressure readings of 172/88, 175/92, and 160/76 mm Hg for 24 hours, daytime and nighttime, respectively.Table 1. Sex Hormone Measurements at 1 y Before and 2 mo After the Present HospitalizationSex hormone1 y before2 mo afterOutpatientInpatientOutpatientLH, mIU/mL11.8 (0.8–6.3)12.4 (1.2–8.6)13.0 (0.8–6.3)FSH, mIU/mL8.6 (0.8–5.1)13.2 (1.3–19.6)12.1 (0.8–5.1)Prolactin, ng/mL15.4 (2.0–18.0)17.0 (2.6–13.1)13.6 (2.0–18.0)Estradiol, pg/mL67.0 (13.5–59.5)35.0 (20.0–47.0)<20 (13.5–59.5)Progesterone, ng/mL0.7 (0.2–1.4)0.9 (0.1–2.1)0.7 (0.2–1.4)Testosterone, ng/mL5.43 (2.6–13.2)6.9 (1.7–7.8)4.7 (2.6–13.2)Values in the parentheses are normal range. The two series of outpatient measurements were performed in the patient's local hospital with different normal ranges from that of inpatient measurements performed in the Ruijin Hospital in Shanghai, China. FSH indicates follicle-stimulating hormone; and LH, luteinizing hormone.His medical history was notable for bilateral cryptorchidism, with left cryptorchidopexy performed when he was 3 years old, whereas the right testis was still in the groin. During that earlier hospitalization, absence of the left kidney and a ureteral malformation were diagnosed, and surgical repair of the ureteral malformation was performed when he was 4 years old. He had no family history of hypertension. A 13-year-old younger brother was found to have right limb inflexibility at birth. Physical examination was normal except for right scrotal vacuity. Secondary sexual characteristics were also normal.After admission, we performed routine blood tests and serum electrolyte measurements, which were unremarkable. Plasma sodium was 140 mmol/L, and plasma potassium was 4.09 mmol/L. Renal function was further assessed. Before admission, his serum creatinine was slightly elevated to 107 μmol/L. After admission to our department and treatment with benazepril for blood pressure control, serum creatinine increased to 120 μmol/L. After withdrawal of benazepril, serum creatinine decreased to the original level. The urinalysis demonstrated normal albumin-to-creatinine ratio, and 24-hour urinary protein excretion was normal. Serum cortisol, circadian rhythm of cortisol (11.01, 6.22, and 1.52 μg/dL at 08:00 AM, 16:00 PM, and 24:00 PM, respectively), 24-hour urinary free cortisol, and 24-hour urinary catecholamines (urinary epinephrine, norepinephrine, and free dopamine) were normal. Plasma aldosterone concentration was slightly elevated both in the supine and upright positions (136.74 and 112.82 pg/mL, respectively), while the 24-hour urinary aldosterone excretion was elevated at 13.16 μg/24 hours. His plasma renin activity was elevated both in the supine and upright positions (4.88 and 7.91 ng/mL per hour, respectively; Table 2). Twenty-four-hour urinary electrolytes showed that urinary sodium and potassium were 101 and 42 mmol/24 hours, respectively. The SRY gene was positive, and the chromosome analysis was normal. His semen, tested twice, showed an ejaculate volume of 1 mL and absent sperm. Growth hormone, ACTH (adrenocorticotropic hormone), and TSH (thyrotropin) were all in the normal range. LH and prolactin were elevated, but estradiol and FSH were normal (Table 1).Table 2. Plasma Aldosterone Concentration and Plasma Renin ActivityBody positionInitial evaluationRepeated measurementsPlasma aldosterone concentration, pg/mLPlasma renin activity, ng/mL·h−1Plasma aldosterone concentration, pg/mLPlasma renin activity, ng/mL·h−1Supine136.7 (29.4–161.5)4.9 (0.1–5.5)107.83.5Upright112.8 (38.1–313.3)7.9 (0.7–17.4)175.67.2Values in the parentheses are normal range.Both ECG and echocardiogram revealed left ventricular hypertrophy. Computed tomography scan showed that both adrenals were normal, but the left kidney was not seen (Figure 1). Magnetic resonance imaging scan confirmed absence of the left kidney and an enlarged right kidney, with possible duplication. Magnetic resonance imaging also showed a 20% to 30% stenosis at the middle portion of the right renal artery (Figure 2). Fundus photography revealed multiple yellowish-white, round, and subretinal lesions (Figure 3).Download figureDownload PowerPointFigure 1. Upper abdominal computed tomography scan. The right (left) and left (right) adrenals were normal. The left kidney (right) was not seen.Download figureDownload PowerPointFigure 2. Upper abdominal magnetic resonance imaging scan (coronal plane). The left kidney was not seen, with an enlarged right kidney that may be duplication abnormalities (left, middle) and a 20% to 30% stenosis at the middle part of the right renal artery (right).Download figureDownload PowerPointFigure 3. Fundus photography with multiple yellowish-white, round, subretinal lesions.Although by review of the history and previous clinical reports the cause of the hypertension may have been attributed to renal dysfunction or secondary hyperaldosteronism, we could not confirm a specific diagnosis. One week later, the patient was discharged. His blood pressure was poorly controlled (≈160/100 mm Hg) with 4 antihypertensive drugs (nifedipine gastrointestinal therapeutic system 30 mg BID, terazosin 2 mg BID, arotinolol 5 mg BID, and clonidine 75 μg TID). Because of this, he returned to our hospital as an outpatient 6 months ago. We reconsidered the causes of hypertension and attempted further differential diagnosis. The congenital dysplasia of the urinary and reproductive system was consistent with Prune belly syndrome. This is a rare disease that consists of an abdominal wall with deficient tissue, dilated urinary tract, and bilateral cryptorchidism.1 However, our patient had no abdominal muscular abnormality. We did an ultrasound examination that revealed a seminal vesicle cyst in the right (Figure 4). On the basis of this new finding, the patient was diagnosed as having Zinner syndrome.Download figureDownload PowerPointFigure 4. A seminal vesicle cyst in size of 12.9×10 mm on the right lower urinary tract on ultrasonography.DiscussionZinner syndrome is a rare congenital abnormality including a triad of unilateral renal agenesis, ipsilateral ejaculatory duct obstruction, and seminal vesicle cyst,2 which may combine with other abnormalities, such as adult polycystic kidney disease, hemivertebra, male fertility disorders, seminal tract alterations, and ipsilateral testicular agenesis.3 Zinner syndrome derives from an anomalous development of the mesonephric or wolffian duct between 4 and 13 weeks of embryogenesis.4 It is a rare disorder with reported frequency of ≈0.0046%.5 Some patients are diagnosed incidentally by urologists because of male infertility. Little attention has been paid to coexisting blood pressure abnormalities, and as a result, few cases had been reported of Zinner syndrome with hypertension. One exception was a case with an obstructing ureteral stone causing upstream hydroureteronephrosis and uncontrolled high blood pressure.6 After the stone was removed, his blood pressure returned to the original level.6 Diagnosis of the syndrome is based principally on imaging modalities, including magnetic resonance imaging, computed tomography, and ultrasonography, which reveal the characteristic cystic dilatations of the seminal vesicle and ipsilateral renal agenesis.7 Seminal vesicle cyst associated with contralateral renal agenesis is an extremely rare condition. To the best of our knowledge, only 5 cases had been published to date in the literature.8–12 It was reported that perhaps the occurrence of these two abnormalities was incidental.9 The unique feature of our case was that the presenting disorder was resistant hypertension.The patient and his younger brother both had congenital dysplasia of the genitourinary or motor systems, respectively. Their parents were not close relatives and denied history of exposure to radioactive substances or harmful chemicals before or during pregnancy. Zinner syndrome is a developmental abnormality of urogenital tract. Genetic factors that provoke abnormal embryogenesis result in many diseases. However, to the best of our knowledge, there is no report on genetic inheritance of Zinner syndrome. Although whole genome sequencing of the patient and his immediate family members would provide genetic information, more cases are needed to verify genetic inheritance of Zinner syndrome, which is not possible to achieve due to low incidence. Despite his genitourinary system dysplasia, this young unmarried male had no follow-up or blood pressure measurements after the ages of 3 to 4 years, when he had the cryptorchidopexy and the surgical repair of the ureteral malformation. We consulted an ophthalmologist who stated that the fundus lesion could be congenital or secondary to hypertension.Speculation about the cause of his high blood pressure was complex. First, solitary kidney most likely caused renal glomerular hyperfiltration and hyperperfusion, which might have induced sympathetic excitation and renin-angiotensin-aldosterone system activation. There was no direct evidence that his sympathetic nervous system was stimulated because his blood and urinary catecholamines were all within the normal reference range. Nonetheless, the activation of the renin-angiotensin-aldosterone system indirectly supports sympathetic activation. Second, renal artery stenosis may havevcontributed to secondaryvhyperaldosteronism. After taking benazepril, the patient's serum creatinine increased, indicating the right renal artery stenosis may have been clinically significant even though imaging suggested there was only a 20% to 30% stenosis of the mid-right renal artery. If a solitary kidney would have had a significant stenosis, benazepril might have caused acute renal failure. Third, the congenital abnormalities of the kidney might have induced juxtaglomerular cell injury in the right kidney, leading to high renin levels.Other possible causes for elevated blood pressure are noteworthy. Rathke cleft cysts are sellar or suprasellar nonneoplastic cystic lesions derived from Rathke pouch, which is a benign growth found on the pituitary gland in the brain.13 Symptomatic cases are relatively rare. The symptoms of cysts are usually attributable to local compression, irritation, and increased intracranial pressure caused by hydrocephalus.13 The most common presenting symptoms include headache, visual disturbance, and pituitary hormone abnormalities, especially hypogonadism and hyperprolactinemia.14 The patient has elevated LH, FSH, and prolactin secreted by the pituitary gland. Estradiol was measured 3× but increased only once possibly as a consequence of the FSH increase. Other possible causes for abnormally high estrogens in men include tumors of the testis (eg, Leydig or Sertoli cell), estrogen-producing adrenal tumors, and the increased estrogen production of abnormal testicular function. As a result, both FSH and cryptorchidism regulate the production of estradiol, which should inhibit FSH production by the pituitary gland through negative feedback. However, with the estradiol increase, FSH was not inhibited, suggesting hypothalamic dysfunction. Unfortunately, we were unable to test his gonadotropin-releasing hormone in our hospital. We considered that the pituitary gland might play a major role in the abnormal hypothalamic-pituitary-gonadal axis of our patient. There are 6 major hormones secreted from the anterior pituitary: growth hormone, prolactin, ACTH, TSH, and gonadotropins (LH and FSH). The patient's hormone evaluation revealed an elevated level of prolactin, LH, and FSH and normal levels of TSH and growth hormone, which was consistent with the most frequent abnormalities caused by Rathke cleft cyst. It has been reported that blood pressure increases when taking combined hormonal contraceptives including estrogen in female, and there is a substantial increase in plasma angiotensinogen concentration, indicating that angiotensinogen is exquisitely sensitive to estrogen stimulation.15 The increase of angiotensinogen induces angiotensin II and aldosterone upregulation that activates the renin-angiotensin-aldosterone system and jointly increases blood pressure. It has also been reported that estrogen increases hepatic angiotensinogen.16 Indeed, in ovariectomized rats injected with estrogen, the expression of angiotensinogen mRNA in the liver, kidneys, and aorta increased.17 In addition to blood pressure elevation through the upregulation of angiotensin, estrogen may also increase blood pressure through water and sodium retention and insulin resistance. These mechanisms all cause blood pressure elevation in cases of obvious excess of estrogen. However, the estrogen levels of this patient were not stable, with high values in the first measurement only (Table 1), when his blood pressure was extremely high. Estrogen levels and blood pressure fluctuated in parallel manner (Table 1), suggesting that estrogen was probably involved in the blood pressure regulation in this patient.The patient's serum creatinine was elevated after taking benazepril, which limited the use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. We, therefore, used a calcium channel blocker, a β-blocker, and other antihypertensive drugs, including an α-blocker, for the treatment of hypertension according to the Chinese hypertension guidelines. Sacubitril/valsartan was recently approved for the treatment of hypertension in China. The patient was readmitted and additionally treated with sacubitril/valsartan 3 months ago. His blood pressure was reduced to a level below 140/90 mm Hg, and serum creatinine was not elevated (100 μmol/L). We repeated the measurements of plasma aldosterone concentration and plasma renin activity, which showed decreases both in the supine and upright positions. Twenty-four-hour urinary aldosterone excretion also decreased substantially (Table 2). The patient's blood pressure decreased probably because of the use of the renin-angiotensin-aldosterone system inhibitors. We reevaluated 24-hour urinary electrolytes and found that urinary sodium and potassium excretions were 78.4 and 28.1 mmol/24 hours, respectively. These measurements suggested that his previously higher urinary potassium excretion was driven by his previously increased aldosterone levels. Inhibition of the renin-angiotensin-aldosterone system was associated with decreased aldosterone secretion and potassium excretion. Urinary sodium excretion was not high, making it unlikely that excess dietary salt intake was a major factor in his hypertension.SummaryThe Zinner syndrome is a rare congenital abnormality comprising a triad of unilateral renal agenesis, ipsilateral ejaculatory duct obstruction, and seminal vesicle cyst. The present case had complicated clinical characteristics including severe and resistant hypertension. We described the diagnostic workup and the management of high blood pressure in this setting.Article InformationSources of FundingNone.Disclosures None.FootnotesThe opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.Presented in part at the Clinical-Pathological Conference chaired by Anna F. Dominiczak and Rhian Touyz at the virtual Hypertension Scientific Sessions 2021, September 28, 2021. Jing Chen, Xin Chen, and Ji-Guang Wang presented the case and led the discussion.For Sources of Funding and Disclosures, see page 1151.Correspondence to: Ji-Guang Wang, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197 Ruijin 2nd Rd, Shanghai 200025, China. Email [email protected]com.cnReferences1. Cornel A, Duicu C, Delean D, Bulata B, Starcea M. Long term follow-up in a patient with prune-belly syndrome - a care compliant case report.Medicine (Baltimore). 2019; 98:e16745. doi: 10.1097/MD.0000000000016745CrossrefMedlineGoogle Scholar2. Hofmann A, Vauth F, Roesch WH. Zinner syndrome and infertility horizontal line a literature review based on a clinical case.Int J Impot Res. 2021; 33:191–195.CrossrefMedlineGoogle Scholar3. Zinner A. Ein fall von intravesikaler samenblasenzyste.Weien Med Wschr. 1914; 64:604–610.Google Scholar4. Florim S, Oliveira V, Rocha D. Zinner syndrome presenting with intermittent scrotal pain in a young man.Radiol Case Rep. 2018; 13:1224–1227. doi: 10.1016/j.radcr.2018.08.012CrossrefMedlineGoogle Scholar5. Farooqui A, AlDhahir L, Mahfooz AB. Massive seminal vesicle cyst with ipsilateral renal agenesis - Zinner syndrome in a Saudi patient.Urol Ann. 2018; 10:333–335. doi: 10.4103/UA.UA_17_18CrossrefMedlineGoogle Scholar6. Yousaf A, Fazeel HM, Shah MH, Ghaffar F, Batool SS. Zinner syndrome unmasked by workup for renal colic and uncontrolled hypertension.Cureus. 2020; 12:e8381. doi: 10.7759/cureus.8381CrossrefMedlineGoogle Scholar7. Naval-Baudin P, Carreño García E, Sanchez Marquez A, Valcárcel José J, Romero NM. Multicystic seminal vesicle with ipsilateral renal agenesis: two cases of Zinner syndrome.Scand J Urol. 2017; 51:81–84. doi: 10.1080/21681805.2016.1257650CrossrefMedlineGoogle Scholar8. Shimamura M, Koizumi H, Hisazumi H. [Seminal vesicle cyst associated with contralateral renal agenesis: a case report].Hinyokika Kiyo. 1984; 30:1263–1267.MedlineGoogle Scholar9. Kosan M, Tul M, Inal G, Ugurlu O, Adsan O. A large seminal vesicle cyst with contralateral renal agenesis.Int Urol Nephrol. 2006; 38:591–592. doi: 10.1007/s11255-005-4982-7CrossrefMedlineGoogle Scholar10. Kondo N, Shiono Y, Yoshino Y, Sugaya S, Abe M, Koshitaka Y. [Papillary adenocarcinoma in a seminal vesicle cyst associated with contralateral renal agenesis: a case report].Hinyokika Kiyo. 2007; 53:175–178.MedlineGoogle Scholar11. El-Assmy A, Abou-El-Ghar ME. Giant seminal vesicle cyst causing ipsilateral hydronephrosis with contralateral renal agenesis.Urology. 2012; 79:e17–e18. doi: 10.1016/j.urology.2011.05.008CrossrefMedlineGoogle Scholar12. Khanduri S, Katyal G, Sharma H, Goyal A, Singh N, Yadav H. Unique association of multiple seminal vesicle cysts with contralateral renal agenesis: a rare variant of zinner syndrome.Cureus. 2017; 9:e1415. doi: 10.7759/cureus.1415CrossrefMedlineGoogle Scholar13. Naik VD, Thakore NR. A case of symptomatic Rathke's cyst.BMJ Case Rep. 2013; 2013:bcr2012006943. doi: 10.1136/bcr-2012-006943CrossrefMedlineGoogle Scholar14. Larkin S, Karavitaki N, Ansorge O. Rathke's cleft cyst.Handb Clin Neurol. 2014; 124:255–269. doi: 10.1016/B978-0-444-59602-4.00017-4CrossrefMedlineGoogle Scholar15. Sitruk-Ware R, Plu-Bureau G, Menard J, Conard J, Kumar S, Thalabard JC, Tokay B, Bouchard P. Effects of oral and transvaginal ethinyl estradiol on hemostatic factors and hepatic proteins in a randomized, crossover study.J Clin Endocrinol Metab. 2007; 92:2074–2079. doi: 10.1210/jc.2007-0026CrossrefMedlineGoogle Scholar16. Clauser E, Gaillard I, Wei L, Corvol P. Regulation of angiotensinogen gene.Am J Hypertens. 1989; 2:403–410. doi: 10.1093/ajh/2.5.403CrossrefMedlineGoogle Scholar17. Gordon MS, Chin WW, Shupnik MA. Regulation of angiotensinogen gene expression by estrogen.J Hypertens. 1992; 10:361–366. doi: 10.1097/00004872-199204000-00007CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetails June 2022Vol 79, Issue 6 Advertisement Article InformationMetrics © 2022 American Heart Association, Inc.https://doi.org/10.1161/HYPERTENSIONAHA.122.18678PMID: 35300529 Originally publishedMarch 18, 2022 PDF download Advertisement SubjectsHigh Blood PressurePreeclampsiaPulmonary Hypertension